DAB2IP and central nervous system cancer: Analysis of The Cancer Genome Atlas (TCGA) database, low-grade glioma including grade I pilocytic through grade III anaplastic patients expressed significantly higher levels of DAB2IP mRNA than high-grade GBM patients (Fig. 1H).